Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
SANDIMMUN NEORAL Kaps 25 mg 50 Stk
Drug
Sandimmun Neoral, Kapseln
Immunsuppressivum
07.15.0. – immunosuppressants
HAM – Human medicine
KAPWE – Capsule, soft
BT – biological medicines
B – Dispensed on prescription by a physician or veterinarian (B)
Z – approved
5/16/1994
12/31/9999
Dosage strength
Sandimmun Neoral 25 mg, Kapseln
Immunsuppressivum
01
Z – approved
Package
7680526560283
In trade from / since 5/16/1994
A/R – Authorised / referenced
50 capsule(s)
028
Z – approved
Declaration
Component
25 mg ciclosporinum
25 mg ethanolum anhydricum
25 mg propylenglycolum
interesterified corn oil
101.25 mg macrogolglyceroli hydroxystearas
E 307
titanii dioxidum
glycerolum (85 per centum)
21.42 mg propylenglycolum
gelatina
E 172 (nigrum)
E 120
aluminii chloridum hexahydricum
natrii hydroxidum
propylenglycolum
hypromellosum
25 mg propylenglycolum
interesterified corn oil
101.25 mg macrogolglyceroli hydroxystearas
E 307
titanii dioxidum
glycerolum (85 per centum)
21.42 mg propylenglycolum
gelatina
E 172 (nigrum)
E 120
aluminii chloridum hexahydricum
natrii hydroxidum
propylenglycolum
hypromellosum
Spezialitätenliste***
SL
-
-
63.15
None
Yes
10%
No
Authorisation holder
7601001300477
Novartis Pharma Schweiz AG
6343 Risch (ZG)
6343 Risch (ZG)
Date of revision of the text
4/29/2025
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.